β Home
βΉοΈ Info
π§Ύ Overview π Core Facts π₯ Video Blog β Ratings π§βπΌ Executives π¬ My Commentsπ‘ Analytics
π’ Company Q&A π οΈ Industry Q&A π Competitors π Stock Swings β‘ SWOT ποΈ PEST π Porter's Five Forces β¨ Score Positive β οΈ Risks π§© Segmentationπ§ Tools
β Due DiligenceFinancial Ratios
Pay attention and research significant changes from year to year values. [ ! ]
Fixed Column | Current Ratio | Quick Ratio | Cash Ratio | Days Of Sales Outstanding | Days Of Inventory Outstanding | Operating Cycle | Days Of Payables Outstanding | Cash Conversion Cycle | Gross Profit Margin | Operating Profit Margin | Pretax Profit Margin | Net Profit Margin | Effective Tax Rate | Return On Assets | Return On Equity | Return On Capital Employed | Net Income Per EBT | EBT Per EBIT | EBIT Per Revenue | Debt Ratio | Debt/Equity Ratio | Long Term Debt To Capitalization | Total Debt To Capitalization | Interest Coverage | Cash Flow To Debt Ratio | Company Equity Multiplier | Receivables Turnover | Payables Turnover | Inventory Turnover | Fixed Asset Turnover | Asset Turnover | Operating Cash Flow Per Share | Free Cash Flow Per Share | Cash Per Share | Payout Ratio | Operating Cash Flow / Sales Ratio | Free Cash Flow / Operating Cash Flow Ratio | Cash Flow Coverage Ratio | Short Term Coverage Ratios | Capital Expenditure Coverage Ratio | Dividend Paid And CAPEX Coverage Ratio | Dividend Payout Ratio | Price Book Value Ratio | Price To Book Ratio | Price To Sales Ratio | Price Earnings Ratio | Price To Free Cash Flows Ratio | Price To Operating Cash Flows Ratio | Price Cash Flow Ratio | Price Earnings To Growth Ratio | Price Sales Ratio | Dividend Yield | Enterprise Value Multiple | Price Fair Value |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2024-12 | 1.81 | 1.32 | 0.55 | 65.93 | 248.25 | 314.19 | 171.03 | 143.16 | 0.55 | 0.22 | 0.19 | 0.15 | 0.23 | 0.06 | 0.11 | 0.11 | 0.76 | 0.87 | 0.22 | 0.21 | 0.44 | 0.28 | 0.3 | 4.38 | 0.35 | 2.04 | 5.54 | 2.13 | 1.47 | 3.47 | 0.38 | 354.78 | 282.83 | 678.45 | 0.75 | 0.2 | 0.8 | 0.35 | 3.53 | 4.93 | 1.32 | 0.75 | 1.79 | 1.79 | 2.3 | 15.64 | 14.43 | 11.5 | 11.5 | -3.95 | 2.3 | 0.05 | 9.48 | 1.79 |
2023-12 | 1.69 | 1.26 | 0.54 | 68.77 | 247.89 | 316.66 | 176.49 | 140.17 | 0.57 | 0.24 | 0.22 | 0.17 | 0.22 | 0.07 | 0.13 | 0.13 | 0.78 | 0.92 | 0.24 | 0.16 | 0.3 | 0.19 | 0.23 | 7.06 | 0.5 | 1.9 | 5.31 | 2.07 | 1.47 | 3.46 | 0.39 | 319.42 | 251.13 | 585.98 | 0.76 | 0.2 | 0.79 | 0.5 | 2.43 | 4.68 | 1.16 | 0.76 | 1.69 | 1.69 | 2.28 | 13.42 | 14.51 | 11.41 | 11.41 | 1.5 | 2.28 | 0.06 | 7.97 | 1.69 |
2022-12 | 1.74 | 1.3 | 0.55 | 68.55 | 231.48 | 300.03 | 180.69 | 119.34 | 0.59 | 0.25 | 0.22 | 0.17 | 0.25 | 0.07 | 0.13 | 0.13 | 0.75 | 0.91 | 0.25 | 0.15 | 0.27 | 0.19 | 0.21 | 7.16 | 0.5 | 1.85 | 5.32 | 2.02 | 1.58 | 3.43 | 0.41 | 272.6 | 216.59 | 509.68 | 0.6 | 0.18 | 0.79 | 0.5 | 3.52 | 4.87 | 1.32 | 0.6 | 1.33 | 1.33 | 1.78 | 10.67 | 12.29 | 9.76 | 9.76 | 0.35 | 1.78 | 0.06 | 5.81 | 1.33 |
2021-12 | 1.55 | 1.17 | 0.48 | 74.67 | 214.83 | 289.5 | 212 | 77.5 | 0.59 | 0.21 | 0.2 | 0.15 | 0.28 | 0.06 | 0.12 | 0.12 | 0.72 | 0.95 | 0.21 | 0.16 | 0.33 | 0.22 | 0.25 | 10.93 | 0.65 | 2.06 | 4.89 | 1.72 | 1.7 | 3.08 | 0.4 | 337.52 | 279.52 | 416.47 | 0.74 | 0.26 | 0.83 | 0.65 | 4.19 | 5.82 | 1.69 | 0.74 | 1.47 | 1.47 | 1.77 | 12.17 | 8.31 | 6.88 | 6.88 | 1.34 | 1.77 | 0.06 | 6.28 | 1.47 |
2020-12 | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** |
2019-12 | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** |
2018-12 | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** |
2017-12 | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** |
2016-12 | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** |
2015-12 | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** |
2014-12 | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** |

π Explore more ratios for Japan Tobacco!
Sign up for free or log in
Have you heard about our short Daily Video Newsletter?
Find out more
Frequently Asked Questions
π What exactly does InsightfulValue do?β
InsightfulValue helps investors analyze public companies with smart tools, highlighting undervalued opportunities based on solid data, not hype.
π How do you identify undervalued stocks?β
We use key metrics like P/E, P/B, cash flow, debt levels, and moreβblended with value-investing principles and proprietary scoring.
π Do you provide real-time stock data?β
We focus on fundamental analysis and not real-time price feeds. Our data is updated regularly for financials, ratios, and risk metrics.
π§ Do I need investing experience to use InsightfulValue?β
Not at all. Our platform is built to be beginner-friendly while still offering advanced tools for experienced investors.
π‘ What makes your analysis different?β
We strip away the noise and show only meaningful dataβSWOTs, margin of safety, 30-year financial trends, peer comparisons, and more.
π° Is there a free version of InsightfulValue?β
Yes! You can explore key features for free. If you want full access to all companies and premium tools, we offer an upgrade.
π Where do you get your financial data?β
We use trusted financial data providers and cross-reference sources to ensure accuracy and depth.
π οΈ What kind of tools are included in premium access?β
Premium users get advanced filters, full financial history, fair value estimations, risk flags, and investment checklists.
π How secure is my data on InsightfulValue?β
We take data privacy seriously. All information is encrypted and we never sell your personal data.
π§Ύ Can I use InsightfulValue for due diligence?β
Absolutely. Our tools are designed to simplify in-depth research and help you confidently evaluate companies before investing.